QVMM Invesco S&P MidCap 400 QVM Multi-factor ETF

Expense Ratio
0.15%
Dividend
1.13%
Previous close
$35.94
Est. 12 months change
+17.02%
Projected Price
$42.06

Profitability Metrics

Return on Equity (ROE)
18.04%
Return on Assets (ROA)
6.36%
Return on Invested Capital (ROIC)
19.17%
Weighted Average Cost of Capital (WACC)
8.56%
ROIC - WACC
10.61%
Updated : 2026-08-19 19:17 ET

Valuation Metrics

P/E Ratio
21.08
Forward P/E
16.39
PEG Ratio
3.83
Debt Current Ratio
2.56

Growth & Cash Flow

Gross Margin
45.34%
Operating Margin
19.98%
FCF Margin
16.85%
TTM Revenue Growth
21.90%
Projected 12M EPS Growth
28.61%

Price Change

Price % from 50 SMA
0.87%
Price % from 200 SMA
8.19%
6 Months
7.28%
1 Year
21.55%
2 Years
27.96%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
P1.32%
TWLO1.04%
FTI0.91%
ATI0.88%
ILMN0.88%
NVT0.87%
OKTA0.84%
ENTG0.80%
CW0.79%
THC0.75%

ETF Analysis

Fund Overview

Invesco S&P MidCap 400 QVM Multi-factor ETF (QVMM) currently reports 355 stock positions (subject to change), placing it in the widely spread range by holdings breadth. The top line-up is P (1.32%), TWLO (1.04%), FTI (0.91%), with P as the largest single weight at 1.32%. Together, the top three holdings account for 3.27%, which points to a relatively flat weight distribution where no single cluster of names dominates outcomes. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.

Profitability & Capital Efficiency

Assessing the quality of returns on invested capital, ROIC is 19.17%, WACC is 8.56%, and the economic spread is 10.61%. On balance, the portfolio's businesses are clearing their capital cost hurdle with room to spare. Supporting metrics show ROE at 18.04% and ROA at 6.36%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

The current pricing of the underlying holdings reads trailing P/E of 21.08, forward P/E of 16.39, PEG of 3.83. The small spread between trailing and forward P/E suggests neither meaningful acceleration nor deterioration is currently priced into the earnings outlook. The PEG reading here is above the range most value-oriented investors would find comfortable — the valuation requires a high degree of confidence in forward earnings delivery. At 2.56, the aggregate current ratio reflects strong balance sheet liquidity across the portfolio. In aggregate, the valuation reads as fair to moderately stretched — leaving the investment case dependent on earnings execution rather than multiple expansion.

Margins & Cash Generation

Looking at margins from gross to free cash flow, gross margin sits at 45.34%, operating margin at 19.98%, and free cash flow margin at 16.85%. Gross margins are constructive — not exceptional, but indicative of businesses with reasonable unit economics. At this level, operating margins reflect businesses that are scaling with discipline without dramatic cost pressure. The portfolio's cash conversion is solid — a sign that operating profits are translating into real liquidity at the fund level. Together, these margins describe a portfolio where business quality varies — and where macro or sector headwinds could disproportionately impact the weaker-margin holdings.

Growth & Forward Outlook

Projected 12-month EPS growth of 28.6% adds a powerful forward signal — analyst consensus expects earnings to accelerate materially, which, if delivered, could make current multiples look increasingly modest. Turning to growth and analyst expectations, TTM revenue growth of 21.90% pointing to sustained and broad-based revenue growth within the basket, while the estimated 12-month price change of 17.19%, where target prices point to mid-range appreciation potential from current levels. The distinction matters: revenue growth tells you what the businesses are doing, price targets tell you what analysts think the market will pay for it. Ultimately, the alignment between revenue momentum and analyst targets will depend on execution quality and the broader rate and sentiment environment. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The quantitative profile, taken as a whole, is above average on virtually every dimension that matters for long-term return generation.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.